ALAN JACKSON KEPT HIS GENETIC ILLNESS PRIVATE FOR A DECADE BEFORE TURNING HIS FINAL TOUR INTO A MILLION-DOLLAR FIGHT FOR A CURE. HE GOT IT FROM HIS FATHER. THERE IS NO TREATMENT. HE SPENT HIS LAST TOUR PAYING FOR ONE ANYWAY. Alan Jackson was diagnosed with Charcot-Marie-Tooth disease in 2011 and said nothing publicly for ten years. When he finally did, on TODAY in 2021, the first thing he explained was where it came from. “It’s genetic. I inherited from my daddy.” Then he laughed at the acronym. CMT — the same three letters as the network that carried his videos for twenty years. It is the most common inherited neuropathy, traced to more than 140 known mutations, affecting about 150,000 Americans and three million people worldwide. It degenerates the peripheral nerves running out to the hands and feet. There are no approved treatments. Not one. He put a dollar from every ticket on the Last Call tour toward the CMT Research Foundation, and a group of the foundation’s donors agreed to match it. By the end it came to more than $2.25 million. The foundation describes what that money funds as drug development aimed at treatments “within our lifetime.” He is sixty-seven and the nerve damage is decades in. He played the last one at Nissan Stadium in Nashville on June 27. A storm pushed him back an hour; he went on after 9:35. Other artists had spent the first two hours singing his catalog. He told the crowd the ride had been long and sweet, and that it started forty years ago that September. The money goes to whoever gets the disease next.

He Got It From His Father

Alan Jackson did not make the announcement lightly. For years, he carried the diagnosis privately, keeping the weight of it off the stage and out of the headlines. When he finally spoke publicly in 2021, he started with the part that made the most sense to him: “It’s genetic. I inherited it from my daddy.”

That detail mattered because it turned a medical condition into a family story. Charcot-Marie-Tooth disease, often shortened to CMT, is an inherited disorder that affects the peripheral nerves in the hands and feet. It can make walking, balance, and hand movement harder over time. It is also a disease without a cure. The CMT Research Foundation says there are currently no known treatments or cures, and the National Institute of Neurological Disorders and Stroke describes CMT as a genetic condition that can be managed, but not reversed.

For Jackson, the diagnosis was not just something to absorb. It was something to explain to fans who had watched him perform for decades. He even joked about the acronym, because CMT also happened to be the name of the television network that helped bring country music into living rooms for years. The laugh did not hide the seriousness. It only showed the kind of grace that has long defined him.

A farewell that became something more

As Jackson prepared for his final touring chapter, his music carried a second purpose. His Last Call tour pledged one dollar from every ticket sold to the CMT Research Foundation, with donors matching the contribution. By the time the tour’s major run wrapped, the total had grown into more than $2.25 million for research. The foundation says its mission is to fund science that can lead to treatments and cures within our lifetime.

That is what gives this story its emotional pull. Jackson was not only saying goodbye to the road. He was helping pay for the next chapter for people who may one day hear the same diagnosis. The money was not symbolic. It was directed toward research, toward the difficult work of finding something that does not yet exist.

The final Nashville night

On June 27, the farewell concert at Nissan Stadium in Nashville became the emotional center of that effort. A storm delayed the show, and Jackson did not take the stage until after 9:35 p.m. Other artists had already spent the first hours honoring his catalog. When he finally stepped forward, he told the crowd the ride had been long and sweet, and that it began forty years earlier that September.

He is sixty-seven now, and the disease is not new inside his body. The damage has had years to do its quiet work. But the legacy of that night was bigger than one performance. It was a promise, turned into action, that the money collected would go where it mattered most.

The music was the farewell, but the gift was the future.

And for the next person who hears those three letters — CMT — the hope is that the story will not end with fear. It will begin with help.

 

You Missed

KEEPING HIS GEAR ON THE BUS FOR FOUR YEARS, ALABAMA WAITED FOR JEFF COOK TO WALK BACK ON STAGE. PARKINSON’S TOOK HIS HANDS. BUT FOR FOUR YEARS, HIS BANDMATES CARRIED HIS EQUIPMENT ON EVERY TOUR — WAITING FOR A NIGHT THAT MIGHT NEVER COME. Jeff Cook co-founded Alabama with his cousins as teenagers playing for tips in a Myrtle Beach bar, six years before anyone cared. Then came 21 straight number ones. Seventy-five million albums. Guitar, fiddle, keyboards — sometimes all in one show. In 2012, a fishing lure he couldn’t cast told him something was wrong. Then came missed notes. Then tremors. Then Parkinson’s. He hid it for five years. When he finally told fans in 2017, he said, “I don’t want the music to stop or the party to end.” He left the road in 2018. But Alabama never replaced him. They kept his gear on every tour bus, night after night, city after city, just in case Jeff Cook walked through the door again. And once, he did. He came back for Alabama’s 50th anniversary — one more walk onto that stage, one more moment with the men who had carried not just his instruments, but the space he left behind. Then on November 7, 2022, Jeff Cook died at home in Florida. He was 73. Some bands replace a member before the bus leaves the lot. Alabama carried his guitar for four years hoping he’d play it one more time. The story behind the night Jeff Cook walked back on that stage — and what happened when the music started — is one of the quietest, most powerful moments in country music history.

ALAN JACKSON KEPT HIS GENETIC ILLNESS PRIVATE FOR A DECADE BEFORE TURNING HIS FINAL TOUR INTO A MILLION-DOLLAR FIGHT FOR A CURE. HE GOT IT FROM HIS FATHER. THERE IS NO TREATMENT. HE SPENT HIS LAST TOUR PAYING FOR ONE ANYWAY. Alan Jackson was diagnosed with Charcot-Marie-Tooth disease in 2011 and said nothing publicly for ten years. When he finally did, on TODAY in 2021, the first thing he explained was where it came from. “It’s genetic. I inherited from my daddy.” Then he laughed at the acronym. CMT — the same three letters as the network that carried his videos for twenty years. It is the most common inherited neuropathy, traced to more than 140 known mutations, affecting about 150,000 Americans and three million people worldwide. It degenerates the peripheral nerves running out to the hands and feet. There are no approved treatments. Not one. He put a dollar from every ticket on the Last Call tour toward the CMT Research Foundation, and a group of the foundation’s donors agreed to match it. By the end it came to more than $2.25 million. The foundation describes what that money funds as drug development aimed at treatments “within our lifetime.” He is sixty-seven and the nerve damage is decades in. He played the last one at Nissan Stadium in Nashville on June 27. A storm pushed him back an hour; he went on after 9:35. Other artists had spent the first two hours singing his catalog. He told the crowd the ride had been long and sweet, and that it started forty years ago that September. The money goes to whoever gets the disease next.